| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKT460 |
| P8608 | Fatcat ID | release_ijahofwmlra4ld7nduwxr6yvni |
| P698 | PubMed publication ID | 24275117 |
| P5875 | ResearchGate publication ID | 258921747 |
| P50 | author | Stefan Schwarz | Q89522081 |
| Andrea T. Feßler | Q113273376 | ||
| Ellen Prenger-Berninghoff | Q113625980 | ||
| Anne Riesenberg | Q114777057 | ||
| Dieter Klarmann | Q114777063 | ||
| Christiane Werckenthin | Q114777064 | ||
| Ivonne Stamm | Q115297579 | ||
| P2093 | author name string | Erdal Erol | |
| Anton Heusinger | |||
| Reinhard Böse | |||
| P2860 | cites work | Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin | Q30857084 |
| Rhodococcus equi infections in immunocompetent hosts: case report and review | Q34136708 | ||
| In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials | Q34937711 | ||
| Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand | Q35027997 | ||
| Rapid identification of Rhodococcus equi by a PCR assay targeting the choE gene | Q35156592 | ||
| Emerging Trend of Mutation Profile of rpoB Gene in MDR Tuberculosis, North India | Q36336385 | ||
| Molecular and infection biology of the horse pathogen Rhodococcus equi | Q37488593 | ||
| Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals | Q39465660 | ||
| Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia | Q40527627 | ||
| Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA. | Q42205018 | ||
| Molecular basis of rifampicin resistance in Haemophilus influenzae. | Q44443524 | ||
| In-vitro antimicrobial susceptibility of Rhodococcus equi | Q45259378 | ||
| Acquired antimicrobial resistance in equine Rhodococcus equi isolates | Q49074655 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rhodococcus equi | Q293148 |
| P304 | page(s) | 1045-1049 | |
| P577 | publication date | 2013-11-24 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin | |
| P478 | volume | 69 |
| Q30245136 | 40 years of veterinary papers in JAC - what have we learnt? |
| Q89510071 | A Novel Screening Strategy Reveals ROS-Generating Antimicrobials That Act Synergistically against the Intracellular Veterinary Pathogen Rhodococcus equi |
| Q41178523 | Activity of 10 antimicrobial agents against intracellular Rhodococcus equi |
| Q40676714 | Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice |
| Q89981353 | Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis |
| Q38825789 | Bacterial resistance to antimicrobial agents and its impact on veterinary and human medicine |
| Q90730479 | Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi |
| Q41672483 | Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi |
| Q92090446 | Effect of Macrolide and Rifampin Resistance on Fitness of Rhodococcus equi during Intramacrophage Replication and In Vivo |
| Q38831053 | Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia. |
| Q41493451 | Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages |
| Q58100691 | Emergence of resistance to macrolides and rifampicin in clinical isolates of from foals in central Kentucky, USA: 1995 to 2017 |
| Q37697676 | Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus. |
| Q40995814 | Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi |
| Q92427462 | Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA |
| Q91611064 | Rhodococcus induced false-positive galactomannan (GM), a biomarker of fungal presentation, in patients with peritoneal dialysis: case reports |
| Q47929445 | Susceptibility testing of Rhodococcus equi: An interlaboratory test |